Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
---|---|---|---|---|---|---|
Vvi19g0042 | ATGCCCTCCATTAACAGCCTTCTCTCTTCTTTACTCATTGCCTTCGCTTTCTTCACAACTCTCACCTTCTCTGCAACTCTCCTCCCAAATAATGAAGTGGAAGCTCTGGAAGAGATCGCGAAAACTCTGGGGAAGACGGACTGGAACTTCAGTGCGGATCCGTGCGGCGGCGAGTGGGGTTGGGCGACGAAGAATCCGGTGAAGGGGTCGGAAAATGCTGTCACTTGTAGCTGCACCAACAACACTGTTTGCCACGTTGTTAGCATAGTCCTCAAGACTCAGAATCTCCCGGGATCTCTCCCACCAGAGCTGGTGAAGCTTCCTTACCTCCAAGAAATTGACTTCACCCGCAACTACCTCAACGGTTCAATCCCTCCAGAATGGGGTACAATGCAACTAGTAAACATTTCTCTGATCGGAAACCAATTAACGGGTTCGATTCCCAAAGAGCTTGGAAACATCTCTACTCTTGCAAACCTAACCGTGGAGTTCAATCAGCTTTCAGGGGTTCTTCCTCAGGAGCTTGGGAATCTGCCCAGTATAGAGAGAATACTTCTTACCTCAAACAACTTCACTGGGGAGTTACCACAAACATTTGCAGGGCTTACCACATTGAAGGACTTTCGGGTTGGAGATAATCAGTTCACAGGAAAGATACCCAATTTTATACAGAACTGGACAAAACTTGAAAAATTAGTGATTCAAGGGAGTGGTTTCAGTGGGCCGATTCCTTCTGGCATTGCCCTTTTGACAAAAATAACTGACTTGAGAATCAGTGACCTGAATGGAACTGAAGCAACTTTTCCACCATTGAGTGATATGAGAGACTTGAAAACACTGATATTGAGGAGTTGCAATATTGTTGACCCGCTACCTGATTACCTTGGGGAAATGACAAAATTGAAAACCCTAGATCTGAGTTTTAACAAACTAACTGGAGAAATTCCAAGCAGCTTTGTCGGTCTATCAAATGCAGATTACATGTATTTTACCGGAAACATGCTAACTGGAGCCGTGCCTGATTGGATGCTGAAAAGAGGAGACAACTATGATCTTTCATACAATAACTTTACTAGTGAAAGCTCAAGAGGATGTCAAGAACGGAGTGTAAATTTGTTTGGAAGCTCATCAGGAGGAAATAACTCTGGAATTGTCTCGTGCTTGAGAAGCTTTAATTGCCCAAAAAAGTTTTACTCCATGCACATAAATTGTGGTGGAAAAGAAGTAATTGTTGATGGAAATACCACATATGAAGATGACACAGATTCTGGTGGACCATCAAAGTTCTATCAGAGTAGAACAAACTGGGCATTCAGCAGCACAGGTCACTTCATGGACGATGACCGCCCTACGGACTCCTTTATTGGGACAAACGTGTCTAGACTCATCATGGAAAATTCTGGACTGTATACAACCGCACGCCTCTCTGCCCTGTCTCTCACTTATTATGGATTCTGTCTGGAAAATGGAAACTACACAGTAAAGCTTCACTTTGCAGAGATCACCTTTACTGATGACAAAACATATAGCAGCCTTGGTAGGCGTTTGTTTGATGTTTATGTTCAGGATAAGTTGGTTCTCAAGGATTTCAATATTGAGGATGAAGCAGGAGGTGTTAGCAAGGAAATCTTAAAATATTTTACTGCAGTTGTGACTAATAATACCTTGGAAATTCGCTTCTATTGGGCTGGGAAAGGGACTACAGGTATCCCAGTTAGAGGAGTTTATGGTCCTCTTATATCAGCTATTTCTGTGGACCCTGATTTTATACCTCCTACCGAAAATGGAAGCAGTAGTATATCTGTTGGCGTTGTGGTTGGCATTGTGGCTGGAGTCATTCTTCTTGTCTTCCTGCTTATAGGTATCCTTTGGTGGAGAGATTGCCTAAGGCGCAAAGATACGTTGGAACAAGAGTTAAAGGGTCTAGATCTGCAGACTGGCTTGTTTACCTTAAGGCAAATTAAGGCTGCAACAAACAACTTTGATGCTGCCAACAAAATTGGAGAAGGTGGATTTGGTTCTGTTTACAAGGGCGTCTTATCCGATGGCACCATAATTGCAGTGAAGCAGCTTTCTTCCAAATCAAAACAAGGAAACCGTGAGTTTGTGAATGAGATAGGCATGATTTCTGCTCTTCAACATCCTCATCTTGTGAAGCTCTATGGCTGTTGTATAGAAGGAAATCAGTTGTTGCTGATATACGAGTACATGGAAAATAACAGCCTCGCTCGTGCTTTGTTTGGCCCCGAAGAATGTCAATTACAATTGGATTGGCCAACTAGACACAGGATCTGTGTTGGCATAGCAAGAGGGTTGGCTTATCTTCATGAAGAATCAAGGCTGAAGATCGTCCACCGAGACATCAAGGCCACAAATGTGCTACTTGATAAGGATCTTAACCCCAAAATATCTGACTTTGGTTTGGCCAAACTTGATGAAGAGGATAACACCCACATTAGCACTCGGATTGCTGGTACATATGGATATATGGCACCTGAATATGCAATGCGGGGCTATTTAACCGACAAAGCAGATGTTTACAGTTTTGGAGTTGTTGCCTTGGAAATTGTCAGTGGAAGAAGCAACACTACTTATAGGCCAAAAGAAGAATCCATCTATCTTCTTGATCGGGCACTCTCTTTAAAAGAGAAGGGGAGCTTAATGGATATAGTTGACCCCAGATTGGGCTCAGACTTCAACAAGGAAGAGGTCATGGCAATGCTCAACATAGCTCTCCTGTGCACGACCATCTCTTCAGCAGTCAGGCCAGCTATGTCATCAGTTGTGAGCATGCTTGAAGGCAGAACTGCTGTTCAGGACATCGTTTCTGATCCCAGTGCTCCCAGTGATGACTTAAAGCTCGAGGAGATGAAGGAGCATTATCGCCACATCCAAGAAAAGAGCATGGGCGTGAGCGAGAGCAAGGCTCAGAGCATGCCAGATGGGCCATGGACTGCTTCTTCATCCATCCCTGATCTCTACCCAGTCAACTTGGATTCTGAATATTGGGAGAAGAGAGATTAA | 3024 | 0.4382 | MPSINSLLSSLLIAFAFFTTLTFSATLLPNNEVEALEEIAKTLGKTDWNFSADPCGGEWGWATKNPVKGSENAVTCSCTNNTVCHVVSIVLKTQNLPGSLPPELVKLPYLQEIDFTRNYLNGSIPPEWGTMQLVNISLIGNQLTGSIPKELGNISTLANLTVEFNQLSGVLPQELGNLPSIERILLTSNNFTGELPQTFAGLTTLKDFRVGDNQFTGKIPNFIQNWTKLEKLVIQGSGFSGPIPSGIALLTKITDLRISDLNGTEATFPPLSDMRDLKTLILRSCNIVDPLPDYLGEMTKLKTLDLSFNKLTGEIPSSFVGLSNADYMYFTGNMLTGAVPDWMLKRGDNYDLSYNNFTSESSRGCQERSVNLFGSSSGGNNSGIVSCLRSFNCPKKFYSMHINCGGKEVIVDGNTTYEDDTDSGGPSKFYQSRTNWAFSSTGHFMDDDRPTDSFIGTNVSRLIMENSGLYTTARLSALSLTYYGFCLENGNYTVKLHFAEITFTDDKTYSSLGRRLFDVYVQDKLVLKDFNIEDEAGGVSKEILKYFTAVVTNNTLEIRFYWAGKGTTGIPVRGVYGPLISAISVDPDFIPPTENGSSSISVGVVVGIVAGVILLVFLLIGILWWRDCLRRKDTLEQELKGLDLQTGLFTLRQIKAATNNFDAANKIGEGGFGSVYKGVLSDGTIIAVKQLSSKSKQGNREFVNEIGMISALQHPHLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEECQLQLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTYGYMAPEYAMRGYLTDKADVYSFGVVALEIVSGRSNTTYRPKEESIYLLDRALSLKEKGSLMDIVDPRLGSDFNKEEVMAMLNIALLCTTISSAVRPAMSSVVSMLEGRTAVQDIVSDPSAPSDDLKLEEMKEHYRHIQEKSMGVSESKAQSMPDGPWTASSSIPDLYPVNLDSEYWEKRD* | 1008 |
Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
---|---|---|---|---|---|---|---|---|
Vvi19g0042 | 1007 | FunFam | Putative LRR receptor-like serine/threonine-protein kinase | 737 | 944 | - | - | |
Vvi19g0042 | 1007 | Gene3D | Phosphorylase Kinase; domain 1 | 627 | 736 | - | - | |
Vvi19g0042 | 1007 | MobiDBLite | consensus disorder prediction | 963 | 994 | - | - | |
Vvi19g0042 | 1007 | Pfam | Leucine rich repeat | 276 | 335 | IPR001611 | GO:0005515 | |
Vvi19g0042 | 1007 | ProSitePatterns | Protein kinases ATP-binding region signature. | 667 | 689 | IPR017441 | GO:0005524 | |
Vvi19g0042 | 1007 | FunFam | probable LRR receptor-like serine/threonine-protein kinase At1g53430 | 630 | 736 | - | - | |
Vvi19g0042 | 1007 | ProSiteProfiles | Protein kinase domain profile. | 661 | 947 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vvi19g0042 | 1007 | Pfam | Malectin domain | 399 | 583 | IPR021720 | - | |
Vvi19g0042 | 1007 | Gene3D | Ribonuclease Inhibitor | 224 | 371 | IPR032675 | - | |
Vvi19g0042 | 1007 | ProSitePatterns | Serine/Threonine protein kinases active-site signature. | 783 | 795 | IPR008271 | GO:0004672|GO:0006468 | |
Vvi19g0042 | 1007 | SMART | serkin_6 | 661 | 932 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vvi19g0042 | 1007 | MobiDBLite | consensus disorder prediction | 970 | 994 | - | - | |
Vvi19g0042 | 1007 | Gene3D | - | 397 | 587 | - | - | |
Vvi19g0042 | 1007 | Gene3D | Ribonuclease Inhibitor | 32 | 157 | IPR032675 | - | |
Vvi19g0042 | 1007 | Gene3D | Ribonuclease Inhibitor | 158 | 223 | IPR032675 | - | |
Vvi19g0042 | 1007 | Pfam | Protein tyrosine and serine/threonine kinase | 664 | 873 | IPR001245 | GO:0004672|GO:0006468 | |
Vvi19g0042 | 1007 | FunFam | Putative leucine-rich repeat receptor-like serine/threonine-protein kinase isoform A | 32 | 190 | - | - | |
Vvi19g0042 | 1007 | SUPERFAMILY | L domain-like | 73 | 342 | - | - | |
Vvi19g0042 | 1007 | Gene3D | Transferase(Phosphotransferase) domain 1 | 737 | 946 | - | - | |
Vvi19g0042 | 1007 | PANTHER | LEUCINE-RICH REPEAT-CONTAINING PROTEIN DDB_G0281931-RELATED | 20 | 968 | - | - | |
Vvi19g0042 | 1007 | CDD | STKc_IRAK | 667 | 934 | - | - | |
Vvi19g0042 | 1007 | FunFam | Putative leucine-rich repeat receptor-like serine/threonine-protein kinase | 397 | 588 | - | - | |
Vvi19g0042 | 1007 | SUPERFAMILY | Protein kinase-like (PK-like) | 645 | 943 | IPR011009 | - | |
Vvi19g0042 | 1007 | FunFam | Leucine-rich repeat transmembrane protein kinase | 198 | 400 | - | - |
Select | Gene | Chromosome | Start | End | Duplicated_type |
---|---|---|---|---|---|
Vvi19g0042 | Vvi-Chr19 | 479812 | 491484 | Dispersed/Tandem |
Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
---|---|---|---|---|---|---|---|---|
Vvi19g0042 | 24 | 981 | Receptor kinase-like Gene Family | AT1G53420 | 56.729 | 0.0 | 1093 |
Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
---|---|---|---|---|---|---|---|
PK | RLK-Pelle_DLSV | Vvi19g0042 | PK_Tyr_Ser-Thr | 3.9e-47 | CL0016 |
Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
---|---|---|---|---|---|---|
Vvi19g0042 | - | - | vvi:100255520 | 1959.11 |